These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 23381494)
1. The role of mometasone furoate nasal spray in the treatment of adenoidal hypertrophy in the adolescents: a prospective, randomized, cross-over study. Yilmaz HB; Celebi S; Sahin-Yilmaz A; Oysu C Eur Arch Otorhinolaryngol; 2013 Sep; 270(10):2657-61. PubMed ID: 23381494 [TBL] [Abstract][Full Text] [Related]
2. Systematic review and meta-analysis of randomized controlled trials on the role of mometasone in adenoid hypertrophy in children. Chohan A; Lal A; Chohan K; Chakravarti A; Gomber S Int J Pediatr Otorhinolaryngol; 2015 Oct; 79(10):1599-608. PubMed ID: 26235732 [TBL] [Abstract][Full Text] [Related]
3. [Clinical observation of mometasone furoate nasal spray combined with montelukast sodium in the treatment of adenoid hypertrophy in children]. Liu W; Chen RJ Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Mar; 31(5):366-368. PubMed ID: 29871263 [No Abstract] [Full Text] [Related]
4. Mometasone furoate intranasal spray is effective in reducing symptoms and adenoid size in children and adolescents with adenoid hypertrophy. Ghafar MHA; Mohamed H; Mohammad NMY; Mohammad ZW; Madiadipoera T; Wang Y; Abdullah B Acta Otorrinolaringol Esp (Engl Ed); 2020; 71(3):147-153. PubMed ID: 31400807 [TBL] [Abstract][Full Text] [Related]
5. Objective reduction in adenoid tissue after mometasone furoate treatment. Rezende RM; Silveira F; Barbosa AP; Menezes UP; Ferriani VP; Rezende PH; Anselmo-Lima WT; Valera FC Int J Pediatr Otorhinolaryngol; 2012 Jun; 76(6):829-31. PubMed ID: 22425063 [TBL] [Abstract][Full Text] [Related]
6. Montelukast combined with intranasal mometasone furoate versus intranasal mometasone furoate; a comparative study in treatment of adenoid hypertrophy. Ras AE; Hamed MH; Abdelalim AA Am J Otolaryngol; 2020; 41(6):102723. PubMed ID: 32950830 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the effects of montelukast, mometasone furoate, and combined therapyon adenoid size: a randomized, prospective, clinical trial with objective data. Tuhanıoğlu B; Erkan SO Turk J Med Sci; 2017 Dec; 47(6):1736-1743. PubMed ID: 29306232 [TBL] [Abstract][Full Text] [Related]
8. A double-blind randomized placebo-controlled trial of topical intranasal mometasone furoate nasal spray in children of adenoidal hypertrophy with otitis media with effusion. Bhargava R; Chakravarti A Am J Otolaryngol; 2014; 35(6):766-70. PubMed ID: 25151658 [TBL] [Abstract][Full Text] [Related]
9. Role of mometasone furoate aqueous nasal spray for management of adenoidal hypertrophy in children. Bhargava R; Chakravarti A J Laryngol Otol; 2014 Dec; 128(12):1060-6. PubMed ID: 25404102 [TBL] [Abstract][Full Text] [Related]
10. The role of mometasone furoate aqueous nasal spray in the treatment of adenoidal hypertrophy in the pediatric age group: preliminary results of a prospective, randomized study. Berlucchi M; Salsi D; Valetti L; Parrinello G; Nicolai P Pediatrics; 2007 Jun; 119(6):e1392-7. PubMed ID: 17533178 [TBL] [Abstract][Full Text] [Related]
11. Intranasal corticosteroids for nasal airway obstruction in children with moderate to severe adenoidal hypertrophy. Zhang L; Mendoza-Sassi RA; César JA; Chadha NK Cochrane Database Syst Rev; 2008 Jul; 2008(3):CD006286. PubMed ID: 18646145 [TBL] [Abstract][Full Text] [Related]